全文获取类型
收费全文 | 2973篇 |
免费 | 381篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 94篇 |
妇产科学 | 66篇 |
基础医学 | 517篇 |
口腔科学 | 68篇 |
临床医学 | 367篇 |
内科学 | 526篇 |
皮肤病学 | 26篇 |
神经病学 | 364篇 |
特种医学 | 93篇 |
外科学 | 352篇 |
综合类 | 64篇 |
一般理论 | 3篇 |
预防医学 | 277篇 |
眼科学 | 82篇 |
药学 | 262篇 |
中国医学 | 1篇 |
肿瘤学 | 159篇 |
出版年
2021年 | 41篇 |
2020年 | 29篇 |
2019年 | 48篇 |
2018年 | 48篇 |
2017年 | 29篇 |
2016年 | 41篇 |
2015年 | 40篇 |
2014年 | 64篇 |
2013年 | 106篇 |
2012年 | 153篇 |
2011年 | 160篇 |
2010年 | 73篇 |
2009年 | 66篇 |
2008年 | 122篇 |
2007年 | 141篇 |
2006年 | 128篇 |
2005年 | 104篇 |
2004年 | 110篇 |
2003年 | 84篇 |
2002年 | 109篇 |
2001年 | 98篇 |
2000年 | 88篇 |
1999年 | 92篇 |
1998年 | 65篇 |
1997年 | 44篇 |
1996年 | 22篇 |
1995年 | 49篇 |
1994年 | 27篇 |
1993年 | 50篇 |
1992年 | 66篇 |
1991年 | 65篇 |
1990年 | 59篇 |
1989年 | 69篇 |
1988年 | 71篇 |
1987年 | 72篇 |
1986年 | 62篇 |
1985年 | 66篇 |
1984年 | 35篇 |
1983年 | 47篇 |
1981年 | 31篇 |
1980年 | 32篇 |
1979年 | 56篇 |
1978年 | 31篇 |
1977年 | 27篇 |
1976年 | 26篇 |
1975年 | 28篇 |
1974年 | 31篇 |
1973年 | 35篇 |
1972年 | 32篇 |
1970年 | 21篇 |
排序方式: 共有3365条查询结果,搜索用时 15 毫秒
11.
12.
13.
14.
Bernice C. Yates 《Research in nursing & health》1995,18(3):193-203
To determine the extent to which social support from the spouse and a health care provider (HCP) is associated with short- and long-term recovery outcomes in individuals after a cardiac illness, 93 patients were interviewed 2 months (short-term) after their event; 73 (78%) subjects responded to a follow-up questionnaire 1 year later (long-term). Tangible aid from the spouse was associated with better short-term psychological recovery. Satisfaction with and more emotional support from the spouse were associated with better short- and long-term psychological recovery outcomes. Greater satisfaction with HCP support was associated with patients' short- and long-term physical recoveries. These results highlight the value of different sources and types of support as having differential effects on physical and psychological recovery outcomes. ©1995 John Wiley & Sons, Inc. 相似文献
15.
R Dixon AM Hughes K Nairn M Sellers JV Kemp RA Yates 《Cephalalgia : an international journal of headache》1998,18(7):468-475
Zolmitriptan (ZomigTM ) is a 5HT1B/1D agonist which has the ability to cross the intact blood-brain barrier to access central as well as peripheral receptors. Because of the potential for central nervous system side effects, this randomized, double-blind, placebo-controlled, 6-period crossover study evaluated the effects of 2.5 and 5 mg doses of zolmitriptan on psychomotor performance and investigated any pharmacodynamic or pharmacokinetic interaction with diazepam. Twelve healthy volunteers received the following "treatments" as single doses: zolmitriptan 2.5 mg, zolmitriptan 5 mg, diazepam 10 mg, zolmitriptan 2.5 mg+diazepam 10 mg, zolmitriptan 5 mg+diazepam 10 mg and placebo. Pre-dose and at 1, 4, 8, and 24 h post-dose, the following validated battery of psychomotor tests was performed: Bond-Lader visual analogue scales (calmness, contentedness, and alertness factors), critical flicker fusion test, choice reaction time (recognition, motor, and total reaction times), finger-tapping test, number cancellation test and digit symbol substitution test. Plasma concentrations of zolmitriptan, its active metabolite, and diazepam and its active metabolites were measured at the same timepoints. Zolmitriptan 2.5 and 5 mg had no effect on psychomotor function when given alone. In contrast, diazepam 10 mg had profound effects, consistent with its sedative properties, but there was no synergism on concomitant administration of either dose of zolmitriptan. Plasma concentrations of zolmitriptan, diazepam, and their respective active metabolites were similar when the two drugs were given alone or in combination. 相似文献
16.
Stephen L. Yates Merouane Bencheri Eric N. Fluhler Patrick M. Lippiello 《Biochemical pharmacology》1995,50(12):2001
Smokers are reported to have a higher density of central nicotinic acetylcholine receptors (nAChRs) that non-smokers at autopsy. Whether this increased receptor density is a response to smoking or a result of genetic variability is not known. While sub-chronic treatment of rats and mice with nicotine results in upregulation of central nAChRs, changes in receptor density in response to cigarette smoke have not been studied previously. In this study, male Sprague-Dawley rats were exposed nose-only for 13 weeks to mainstream cigarette smoke followed by assessment of [3H]nicotine binding in five brain regions of smoke- and sham-exposed animals. In smoke-exposed animals, there was a significant increase in nAChR density in the cortex, striatum, and cerebellum (35, 25, and 31% increases, respectively), while there was no significant change in receptor density in the thalamus and hippocampus. Smoke exposure did not alter markedly the affinity of the receptor for nicotine in these brain regions. Furthermore, up-regulation of nAChRs did not alter the biphasic binding properties by which nicotine binds to its receptor. There were no changes in the association (fast phase) or isomerization (slow phase) rate constants, and the percent contribution of slow and fast phase binding to nAChRs was not altered in the up-regulated receptor population compared with control. Similar results were observed following chronic nicotine exposure of cultured cortical cells from fetal rat brain or cells transfected with the α4β2 nAChR subtype. These results show that the up-regulation following smoke exposure in the rat is phenomenologically similar to that observed in vitro. These data provide preliminary evidence for a relationship between cigarette smoking and nAChR up-regulation in vivo and suggest that similar mechanisms of upregulation may underlie chronic smoke exposure of live animals and nicotine exposure of artificially expressed α4β2 receptors in vitro. 相似文献
17.
18.
Parental and professional responses to questionnaires evaluating a paediatric disability service are reported and the viability of auditing structural, process, and outcome aspects of clinical practice are discussed. Expectations of waiting time to first appointment (met for only 52% of consumers) illustrate structural issues. Process issues are reflected in consumer reactions to outreach work (for example, 94% of parents and 84% of professionals found this supportive). Outcome measures such as consumer satisfaction with the service (76% of consumers reported being 'very satisfied' and 20% 'fairly satisfied') suggest that service aims are being met. Good concurrence of service aims with consumer needs is indicated by parental reasons for referral (for example, 75% for diagnostic help, 73% for a better understanding of the disorder, 88% for practical help), referrers' reasons (for example, 55% for a second diagnostic opinion, 45% due to lack of local expertise), and reports from most other professionals involved with the case that a similar service was not provided locally. 相似文献
19.
S. Hussey P. H. Gibson R. A. Elton C. M. Yates J. E. Christie P. A. M. Eagles A. Gordon 《Acta neuropathologica》1988,75(5):495-501
Summary Temporal cortex from 14 cases of Alzheimer-type dementia and 6 cases of Down's syndrome, all selected for severe Alzheimer pathology, was homogenised in distilled water, NaOH, or sodium dodecylsulphate (SDS) containing 0.1% -mercaptoethanol. The homogenates were stained with Congo red, and the neurofibrillary tangles and plaque cores were counted under crossed-polarisation microscopy. The number of tangles and plaque cores in the water-treated extracts was not related to age, sex, postmortem interval or duration of dementia. The number of tangles after extraction in SDS or NaOH, as a percentage of tangles in water-treated extracts, was 57±25 (mean±SD) for 1% SDS, 43±17 for 5% SDS and 37±22 for 0.2 M NaOH. Plaque cores were essentially insoluble in all three agents. The percentage of tangles insoluble in 1% SDS did not correlated with age or post-mortem interval but decreased with increasing duration of dementia. Enhanced tangle solubility with increasing duration of dementia suggests that the nature of tangles changes with time; one possibility is that this reflects transformation of intracellular to extracellular tangles. Paired helical filament (PHF) length and the number of repeats per PHF were measured in electron micrographs of PHF prepared with and without treatment by 1% SDS. There was no significant multimodality of PHF length to suggest that PHF broke at regular intervals. The mean repeat length (PHF length/number of repeats) was greater for PHF isolated in the presence of 1% SDS than in its absence, showing that SDS affects ultrastructure by untwisting PHF. An untwisting process may also occur in vivo producing the straight filaments found, together with PHF, in tangles and neurites.Supported by Miss E. Buchan (to the MRC Brain Metabolism Unit) and the British Foundation for Age Research and the Wellcome Trust (to P. A. M. Eagles). S. Hussey was in receipt of an MRC Partnership Award. 相似文献
20.
Scott E. Guimond Susannah J. Patey Edwin A. Yates Jeremy E. Turnbull 《International journal of experimental pathology》2004,85(4):A62-A63
Introduction Fibroblast growth factors (FGFs) are a multipotent family of growth factors that are important for many biological processes, including development and wound healing. Normal, protease sensitive, prion protein (PrPC) can be converted to the protease resistant, infectious, form (PrPSc) believed to be associated with the pathogenesis of transmissible spongiform encephalopathies. FGFs signal through a family of tyrosine kinase receptors, the FGF receptors (FGFR) with the aid of heparan sulfate (HS), while the role of HS in the biology of PrPC is currently unknown, although depleting cells of HS can prevent production of PrPSc. HS, or its more highly sulfated relation heparin, can exert both positive and negative regulatory activities on a particular FGF‐FGFR combination. The nature of this regulation is determined by the structure of the HS that binds to the proteins. This structure is at least partially determined by the presence of particular sulfate groups along the sugar backbone. Identification of specific sulfate groups that can regulate the activity of proteins has been a long‐term goal in the field. Previously, heparins that had been completely lacking sulfates at specific positions were used to determine the binding and activity requirements for a particular protein. However, this may not necessarily allow for a full examination of the regulatory properties of HS. Here, we present a heparan sulfate analogue library produced by the partial, combinatorial desulfation of heparin. This library was the used to examine the structural properties of heparin required for FGF‐1 signalling through FGFR2c as well as the interactions of HS with PrPC. Materials and methods Porcine intestinal mucosal heparin was subjected to chemical desulfation and enzymatic cleavage. Polysaccharides and oligosaccharides derived from gel filtration chromatography and ion exchange chromatography were tested for their ability to activate FGF signalling through FGF receptors using a BaF3 assay system. Optical biosensors and cell assays were used to study the interaction of PrPC with chemically modified heparin. Results This library possessed vastly more heterogeneity than tissue heparan sulfates, allowing for more systematic screening to help identify those minimal structural features associated with activity. This library was used to examine the different structural features in heparin that support FGF‐1 signalling through FGFR2, showing that HS activity was not strictly dependant on size or charge. In addition, small, low‐sulfated heparins were found to interfere with the PrPC–heparin interaction. Discussion This supports the idea that overall structural features of the HS, rather than just the presence or absence of specific sulfate groups is important for the regulation of protein activity. Future efforts will be focused on further subfractionating the library and identifying specific structural features in HS that support FGF‐1 activity through FGFR2 and other FGFRs as well as the role of HS in the normal function of prion diseases, which may allow for the generation of novel, heparin‐based, therapeutics. 相似文献